Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Goodwill & Intangibles (2016 - 2026)

Myriad Genetics has reported Goodwill & Intangibles over the past 16 years, most recently at $205.0 million for Q4 2025.

  • Quarterly Goodwill & Intangibles fell 62.64% to $205.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $205.0 million through Dec 2025, down 62.64% year-over-year, with the annual reading at $205.0 million for FY2025, 62.64% down from the prior year.
  • Goodwill & Intangibles was $205.0 million for Q4 2025 at Myriad Genetics, down from $214.7 million in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $888.2 million in Q1 2021 and troughed at $205.0 million in Q4 2025.
  • The 5-year median for Goodwill & Intangibles is $630.2 million (2022), against an average of $576.4 million.
  • Year-over-year, Goodwill & Intangibles increased 5.91% in 2023 and then crashed 64.14% in 2025.
  • A 5-year view of Goodwill & Intangibles shows it stood at $643.3 million in 2021, then increased by 3.61% to $666.5 million in 2022, then decreased by 4.44% to $636.9 million in 2023, then decreased by 13.85% to $548.7 million in 2024, then crashed by 62.64% to $205.0 million in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Goodwill & Intangibles are $205.0 million (Q4 2025), $214.7 million (Q3 2025), and $221.7 million (Q2 2025).